217 related articles for article (PubMed ID: 16918690)
1. Role of dendritic cells in Sjögren's syndrome.
Vogelsang P; Jonsson MV; Dalvin ST; Appel S
Scand J Immunol; 2006 Sep; 64(3):219-26. PubMed ID: 16918690
[TBL] [Abstract][Full Text] [Related]
2. The complexity of Sjögren's syndrome: novel aspects on pathogenesis.
Jonsson R; Vogelsang P; Volchenkov R; Espinosa A; Wahren-Herlenius M; Appel S
Immunol Lett; 2011 Dec; 141(1):1-9. PubMed ID: 21777618
[TBL] [Abstract][Full Text] [Related]
3. Levels of plasmacytoid dendritic cells and type-2 myeloid dendritic cells are reduced in peripheral blood of patients with primary Sjogren's syndrome.
Vogelsang P; Brun JG; Oijordsbakken G; Skarstein K; Jonsson R; Appel S
Ann Rheum Dis; 2010 Jun; 69(6):1235-8. PubMed ID: 19914903
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of Disease: primary Sjögren's syndrome and the type I interferon system.
Nordmark G; Alm GV; Rönnblom L
Nat Clin Pract Rheumatol; 2006 May; 2(5):262-9. PubMed ID: 16932699
[TBL] [Abstract][Full Text] [Related]
5. Salivary gland and peripheral blood T helper 1 and 2 cell activity in Sjögren's syndrome compared with non-Sjögren's sicca syndrome.
van Woerkom JM; Kruize AA; Wenting-van Wijk MJ; Knol E; Bihari IC; Jacobs JW; Bijlsma JW; Lafeber FP; van Roon JA
Ann Rheum Dis; 2005 Oct; 64(10):1474-9. PubMed ID: 15817659
[TBL] [Abstract][Full Text] [Related]
6. [Peripheral blood dendritic cell dysfunction in patients with Sjögren's syndrome].
Odagiri S
Arerugi; 1999 Apr; 48(4):451-8. PubMed ID: 10355149
[TBL] [Abstract][Full Text] [Related]
7. Follicular dendritic cells confirm lymphoid organization in the minor salivary glands of primary Sjögren's syndrome.
Jonsson MV; Skarstein K
J Oral Pathol Med; 2008 Oct; 37(9):515-21. PubMed ID: 18662248
[TBL] [Abstract][Full Text] [Related]
8. Lymphocytic infiltration and goblet cell marker alteration in the conjunctiva of the MRL/MpJ-Fas(lpr) mouse model of Sjögren's syndrome.
Diebold Y; Chen LL; Tepavcevic V; Ferdman D; Hodges RR; Dartt DA
Exp Eye Res; 2007 Mar; 84(3):500-12. PubMed ID: 17208228
[TBL] [Abstract][Full Text] [Related]
9. IL-14 alpha, the nexus for primary Sjögren's disease in mice and humans.
Shen L; Suresh L; Li H; Zhang C; Kumar V; Pankewycz O; Ambrus JL
Clin Immunol; 2009 Mar; 130(3):304-12. PubMed ID: 19038581
[TBL] [Abstract][Full Text] [Related]
10. New concepts in the pathogenesis of Sjögren's syndrome.
Delaleu N; Jonsson MV; Appel S; Jonsson R
Rheum Dis Clin North Am; 2008 Nov; 34(4):833-45, vii. PubMed ID: 18984407
[TBL] [Abstract][Full Text] [Related]
11. Pathophysiology of Sjögren's syndrome.
García-Carrasco M; Fuentes-Alexandro S; Escárcega RO; Salgado G; Riebeling C; Cervera R
Arch Med Res; 2006 Nov; 37(8):921-32. PubMed ID: 17045106
[TBL] [Abstract][Full Text] [Related]
12. Antimalarials in Sjögren's syndrome--the Greek experience.
Manoussakis MN; Moutsopoulos HM
Lupus; 1996 Jun; 5 Suppl 1():S28-30. PubMed ID: 8803907
[TBL] [Abstract][Full Text] [Related]
13. Immunohistopathology of Sjögren's syndrome.
Konttinen YT; Porola P; Konttinen L; Laine M; Poduval P
Autoimmun Rev; 2006 Nov; 6(1):16-20. PubMed ID: 17110311
[TBL] [Abstract][Full Text] [Related]
14. Lack of CCR5 on dendritic cells promotes a proinflammatory environment in submandibular glands of the NOD mouse.
Wildenberg ME; van Helden-Meeuwsen CG; van de Merwe JP; Moreno C; Drexhage HA; Versnel MA
J Leukoc Biol; 2008 May; 83(5):1194-200. PubMed ID: 18285404
[TBL] [Abstract][Full Text] [Related]
15. Sjögren's syndrome: mechanisms of pathogenesis involve interaction of immune and neurosecretory systems.
Fox RI; Stern M
Scand J Rheumatol Suppl; 2002; 116():3-13. PubMed ID: 12109541
[TBL] [Abstract][Full Text] [Related]
16. Rates of infiltration by macrophages and dendritic cells and expression of interleukin-18 and interleukin-12 in the chronic inflammatory lesions of Sjögren's syndrome: correlation with certain features of immune hyperactivity and factors associated with high risk of lymphoma development.
Manoussakis MN; Boiu S; Korkolopoulou P; Kapsogeorgou EK; Kavantzas N; Ziakas P; Patsouris E; Moutsopoulos HM
Arthritis Rheum; 2007 Dec; 56(12):3977-88. PubMed ID: 18050195
[TBL] [Abstract][Full Text] [Related]
17. Autoimmune diseases and Sjogren's syndrome: an autoimmune exocrinopathy.
Fox PC
Ann N Y Acad Sci; 2007 Mar; 1098():15-21. PubMed ID: 17332090
[TBL] [Abstract][Full Text] [Related]
18. Sjögren's syndrome.
Delaleu N; Jonsson R; Koller MM
Eur J Oral Sci; 2005 Apr; 113(2):101-13. PubMed ID: 15819815
[TBL] [Abstract][Full Text] [Related]
19. Neuroendocrine dysfunction in Sjogren's syndrome.
Tzioufas AG; Tsonis J; Moutsopoulos HM
Neuroimmunomodulation; 2008; 15(1):37-45. PubMed ID: 18667798
[TBL] [Abstract][Full Text] [Related]
20. An important role for B-cell activation factor and B cells in the pathogenesis of Sjögren's syndrome.
Mackay F; Groom JR; Tangye SG
Curr Opin Rheumatol; 2007 Sep; 19(5):406-13. PubMed ID: 17762603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
